| Dr Daniel Henlee Smith, MD | |
|
415 S 28th Ave, Hattiesburg, MS 39401-7246 | |
| (601) 268-5660 | |
| (601) 268-5759 |
| Full Name | Dr Daniel Henlee Smith |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 17 Years |
| Location | 415 S 28th Ave, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689858177 | NPI | - | NPPES |
| 03735792 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 22040 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Home Care | Hattiesburg, MS | Home health agency |
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hattiesburg Clinic, Pa | 5193706794 | 489 |
News Archive
Johnson & Johnson, the world's largest health care products maker, is in the midst of more than 10,000 lawsuits claiming that its iconic baby powder is linked to cancer.
A new study of breast cancer survivors may help physicians ease a common side effect of cancer treatments. The collaborative research by Eva Sevick, Ph.D., Director of the Center for Molecular Imaging at the University of Texas Health Science Center in Houston, and Caroline Fife, M.D., Director of the Memorial Herman Wound Care Clinic at UTHSC, could bring relief to millions.
More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
Anti-tobacco efforts by U.S. states were "abysmal" last year as their collective spending on anti-smoking programs declined 11 percent and only two raised cigarette taxes, the American Lung Association said. While more than half the states already ban the use of cigarettes in restaurants, bars and workplaces, no additional states passed comprehensive anti-smoking laws last year, the Washington-based health advocacy group said today in a report.
› Verified 6 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
Johnson & Johnson, the world's largest health care products maker, is in the midst of more than 10,000 lawsuits claiming that its iconic baby powder is linked to cancer.
A new study of breast cancer survivors may help physicians ease a common side effect of cancer treatments. The collaborative research by Eva Sevick, Ph.D., Director of the Center for Molecular Imaging at the University of Texas Health Science Center in Houston, and Caroline Fife, M.D., Director of the Memorial Herman Wound Care Clinic at UTHSC, could bring relief to millions.
More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
Anti-tobacco efforts by U.S. states were "abysmal" last year as their collective spending on anti-smoking programs declined 11 percent and only two raised cigarette taxes, the American Lung Association said. While more than half the states already ban the use of cigarettes in restaurants, bars and workplaces, no additional states passed comprehensive anti-smoking laws last year, the Washington-based health advocacy group said today in a report.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Henlee Smith, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 268-5660 | Dr Daniel Henlee Smith, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 268-5660 |
News Archive
Johnson & Johnson, the world's largest health care products maker, is in the midst of more than 10,000 lawsuits claiming that its iconic baby powder is linked to cancer.
A new study of breast cancer survivors may help physicians ease a common side effect of cancer treatments. The collaborative research by Eva Sevick, Ph.D., Director of the Center for Molecular Imaging at the University of Texas Health Science Center in Houston, and Caroline Fife, M.D., Director of the Memorial Herman Wound Care Clinic at UTHSC, could bring relief to millions.
More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
Anti-tobacco efforts by U.S. states were "abysmal" last year as their collective spending on anti-smoking programs declined 11 percent and only two raised cigarette taxes, the American Lung Association said. While more than half the states already ban the use of cigarettes in restaurants, bars and workplaces, no additional states passed comprehensive anti-smoking laws last year, the Washington-based health advocacy group said today in a report.
› Verified 6 days ago
Dr. William Duncan Donald Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6051 Us Hwy 49, Hattiesburg, MS 39401 Phone: 601-288-2690 Fax: 601-288-2695 | |
Ralph E Abraham, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5660 Fax: 601-268-5759 | |
Petra R Schneider-redden, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-261-3690 Fax: 601-261-3684 | |
Dr. Matthew Christopher Byrnes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5650 Fax: 601-579-5240 | |
Dr. Cesar R Romero, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6051 U S Highway 49, Hattiesburg, MS 39401 Phone: 601-288-2690 Fax: 601-288-2695 | |
Dr. Kirk J Banquer, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 6051 U S Highway 49, Hattiesburg, MS 39401 Phone: 601-288-2690 Fax: 601-288-2695 | |
Rachel Kaitlin Rosado, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5660 |